CAMBRIDGE INNOVATION CAPITAL
CMR SURGICAL IMPACT CASE STUDIES
TRANSFORMING SURGERY. FOR GOOD.
IMP RATING: B – BENEFIT STAKEHOLDERS CMR Surgical has grown rapidly over the past few years with Versius, our next-generation surgical robotic system, now being used in hospitals across the world to transform the way keyhole surgery is performed. Our success is in no small part thanks to CIC, who has always had the long-term vision to support CMR. Since its initial investment, CIC has continued to support our growth and has always shared in our mission to transform surgery, for good. PER VERGARD NERSETH CEO We have applied the Impact Management Project (IMP) framework (see IBC for further details) in summarising the impact of a selection of our investments.
20
IMPACT AND ESG REPORT FOR THE YEAR ENDED 31 MARCH 2021
